Epstein Secrets

Exhibit 0: Option Pricing Method Analysis Exhibit P: Adjustment for Lack of Marketability William L Silber Study Management Planning, Inc. Study FMV Study Selected Marketability Discount Exhibit Q: Put Option Analysis Appendices Appendix 1: Guideline Company Tear Sheets Appendix 2: Studies Regardin

7% 2012 124.8 89.7 10.3% 2013 138.9 99.9 11.3% 2014 155.3 111.7 11.8% CAGR: 2009-14 Source: Datamonitor 10.1% DATAMONITOR • Sources: Standard & Poor's Industry Surveys (n, the Datamonitor Group, and information provided by management. CONFIDENTIAL I WTAS LLC 13 EFTA00307408 WTAS ALIPHCOM - COMMON EQUITY VALU

Exhibit 0: Option Pricing Method Analysis Exhibit P: Adjustment for Lack of Marketability William L Silber Study Management Planning, Inc. Study FMV Study Selected Marketability Discount Exhibit Q: Put Option Analysis Appendices Appendix 1: Guideline Company Tear Sheets Appendix 2: Studies Regardin

7% 2012 124.8 89.7 10.3% 2013 138.9 99.9 11.3% 2014 155.3 111.7 11.8% CAGR: 2009-14 Source: Datamonitor 10.1% DATAMONITOR • Sources: Standard & Poor's Industry Surveys (n, the Datamonitor Group, and information provided by management. CONFIDENTIAL I WTAS LLC 13 EFTA00307307 WTAS ALIPHCOM - COMMON EQUITY VALU

Exhibit 0: Option Pricing Method Analysis Exhibit P: Adjustment for Lack of Marketability William L Silber Study Management Planning, Inc. Study FMV Study Selected Marketability Discount Exhibit Q: Put Option Analysis Appendices Appendix 1: Guideline Company Tear Sheets Appendix 2: Studies Regardin

7% 2012 124.8 89.7 10.3% 2013 138.9 99.9 11.3% 2014 155.3 111.7 11.8% CAGR: 2009-14 Source: Datamonitor 10.1% DATAMONITOR • Sources: Standard & Poor's Industry Surveys (n, the Datamonitor Group, and information provided by management. CONFIDENTIAL I WTAS LLC 13 EFTA00307206 WTAS ALIPHCOM - COMMON EQUITY VALU